This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.

eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
New eMC coming June 2013...

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 06/01/2011
SPC Boots Magnesium Sulphate Paste BP


Go to top of the page
1. Name of the medicinal product

Magnesium Sulphate Paste BP.


Go to top of the page
2. Qualitative and quantitative composition

Name of ingredient Quantity

Dried Magnesium Sulphate (78.8 – 85.8%) 47.762g

Phenol 0.497g

Phenol is of BP quality.


Go to top of the page
3. Pharmaceutical form

Paste.


Go to top of the page
4. Clinical particulars

Go to top of the page
4.1 Therapeutic indications

As an adjunct to the management of superficial skin infections, including boils.


Go to top of the page
4.2 Posology and method of administration

Method of Administration External application to the affected area.

Posology External paste applied directly.

Adults, elderly and children There is no difference in the quantity required for affected areas or for children, adults or the elderly.


Go to top of the page
4.3 Contraindications

None known.


Go to top of the page
4.4 Special warnings and precautions for use

Do not use repeatedly.

Use as directed on medical advice.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No significant clinical interactions known.


Go to top of the page
4.6. Pregnancy and lactation

As with all medicines it may be used during this period if the benefits outweigh the risks.


Go to top of the page
4.7 Effects on ability to drive and use machines

Not applicable.


Go to top of the page
4.8 Undesirable effects

None known.


Go to top of the page
4.9 Overdose

Should accidental ingestion occur, treat symptomatically.


Go to top of the page
5. Pharmacological properties

Go to top of the page
5.1 Pharmacodynamic properties

Topical application of the ingredients of the paste help to draw infected wounds and reduce inflammation.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

Not applicable.


Go to top of the page
6. Pharmaceutical particulars

Go to top of the page
6.1 List of excipients

Name of ingredient Quantity

Glycerol 51 .7g


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

3 years.


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.


Go to top of the page
6.5 Nature and contents of container

Polypropylene tub and lid with tie sealed tamper evident top containing 25g or 50g.

HDPE tub and lid with tie sealed tamper evident top containing 25g or 50g.


Go to top of the page
6.6 Special precautions for disposal and other handling

Stir well before use and apply liberally to the affected area.

Cover with a dressing.


Go to top of the page
7. Marketing authorisation holder

KL Pharmaceutical Limited

21 Macadam Place

South Newmoor Industrial Estate

Irvine

Ayrshire

KA11 4HP


Go to top of the page
8. Marketing authorisation number(s)

PL 3436/0002.


Go to top of the page
9. Date of first authorisation/renewal of the authorisation

29th February 1991.


Go to top of the page
10. Date of revision of the text

23/03/2007



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/24070/SPC/


Active Ingredients/Generics